Catherine Bollard serves as Executive at Cabaletta Bio, Inc., where they oversee executive responsibilities. Since joining the company, Catherine Bollard has executed 2 insider transactions totaling $11.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 21, 2026 involved purchasing 4,405 shares valued at $10.0K.
Catherine Bollard currently holds 5,405 shares of Cabaletta Bio, Inc. (CABA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Catherine Bollard has been a net buyer of CABA stock. They have purchased $11.0K and sold $0 worth of shares.
Catherine Bollard's most recent insider trade was on Jan 21, 2026, when they purchased 4,405 shares at $2.27 per share.
Get notified when new Form 4 filings are submitted
| $0.99 |
| Discretionary |